Approvals/TGA/QTERN 5/10 saxagliptin (as hydrochloride) / dapagliflozin (as propanediol monohydrate) 5 mg / 10 mg film-coated tablet blister pack

Approved

STANDARD

QTERN 5/10 saxagliptin (as hydrochloride) / dapagliflozin (as propanediol monohydrate) 5 mg / 10 mg film-coated tablet blister pack

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ef0ab022efaa38c9
Product Name: QTERN 5/10 saxagliptin (as hydrochloride) / dapagliflozin (as propanediol monohydrate) 5 mg / 10 mg film-coated tablet blister pack
Artg Id: 255632
Artg Name: QTERN 5/10 saxagliptin (as hydrochloride) / dapagliflozin (as propanediol monohydrate) 5 mg / 10 mg film-coated tablet blister pack
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2016-10-25
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/5a86ec33df577a1a6a2f51cbafab70e7.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/88bd75cb3a3c2db7902e5fbcc21c86fe.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ef0ab022efaa38c9

Type

Standard